Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes.

Resjö S, Göransson O, Härndahl L, Zolnierowicz S, Manganiello V, Degerman E.

Cell Signal. 2002 Mar;14(3):231-8.

PMID:
11812651
3.

Serine/threonine protein phosphatases PP1 and PP2A are key players in apoptosis.

Garcia A, Cayla X, Guergnon J, Dessauge F, Hospital V, Rebollo MP, Fleischer A, Rebollo A.

Biochimie. 2003 Aug;85(8):721-6. Review.

PMID:
14585537
4.

Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.

McCluskey A, Sim AT, Sakoff JA.

J Med Chem. 2002 Mar 14;45(6):1151-75. Review. No abstract available.

PMID:
11881984
5.

A pharmacophore model of tautomycin, an inhibitor of protein phosphatases 1 and 2A.

Ubukata M, Koshino H, Yamasaki C, Fujita K, Isono K.

J Antibiot (Tokyo). 1997 Oct;50(10):801-7. Review. No abstract available.

6.

[Tumor promotion by inhibitors of protein phosphatase 1 and 2A].

Suganuma M, Fujiki H.

Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1102-10. Review. Japanese. No abstract available.

PMID:
9655968
7.

[Naturally occurring toxins with specific inhibitory activity against protein serine/threonine phosphatases 1 and 2A].

Takai A.

Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1091-101. Review. Japanese. No abstract available.

PMID:
9655967
8.

Tautomycin's interactions with protein phosphatase 1.

Sydnes MO, Isobe M.

Chem Asian J. 2010 Mar 1;5(3):410-20. doi: 10.1002/asia.200900394. Review.

PMID:
20013999
9.

Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.

Fujiki H, Suganuma M.

Adv Cancer Res. 1993;61:143-94. Review. No abstract available.

PMID:
8394044
10.

Role of PP2A in intracellular signal transduction pathways.

Schönthal AH.

Front Biosci. 1998 Dec 15;3:D1262-73. Review.

PMID:
9851914
11.

Okadaic Acid: a tool to study the hippo pathway.

Hata Y, Timalsina S, Maimaiti S.

Mar Drugs. 2013 Mar 14;11(3):896-902. doi: 10.3390/md11030896. Review.

12.

Phospholipase C-related but catalytically inactive protein, PRIP as a scaffolding protein for phospho-regulation.

Sugiyama G, Takeuchi H, Kanematsu T, Gao J, Matsuda M, Hirata M.

Adv Biol Regul. 2013 Sep;53(3):331-40. doi: 10.1016/j.jbior.2013.07.001. Epub 2013 Jul 17. Review.

PMID:
23911386
13.

[Total synthesis and conformational analysis of inhibitors].

Tsuboi K, Isobe M.

Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1083-90. Review. Japanese. No abstract available.

PMID:
9655966
14.

Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins.

Sheppeck JE 2nd, Gauss CM, Chamberlin AR.

Bioorg Med Chem. 1997 Sep;5(9):1739-50. Review.

PMID:
9354230
15.

Ceramide-activated protein phosphatase: partial purification and relationship to protein phosphatase 2A.

Dobrowsky RT, Hannun YA.

Adv Lipid Res. 1993;25:91-104. Review. No abstract available.

PMID:
8396314
16.

[Genomic instability induced by a protein phosphatase inhibitor okadaic acid].

Nakagama H, Nagao M.

Tanpakushitsu Kakusan Koso. 1998 Jun;43(8 Suppl):1111-7. Review. Japanese. No abstract available.

PMID:
9655969
17.

Biotherapeutic potential and synthesis of okadaic acid.

Forsyth CJ, Dounay AB, Sabes SF, Urbanek RA.

Ernst Schering Res Found Workshop. 2000;(32):57-102. Review. No abstract available.

PMID:
11077606
18.

[Role of protein phosphatase in the modulation of ion channel activity].

Zhou SS, Zang YM.

Sheng Li Ke Xue Jin Zhan. 1997 Jul;28(3):277-9. Review. Chinese. No abstract available.

PMID:
11038745
Items per page

Supplemental Content

Write to the Help Desk